Fas-Deficient Target Cells Perforin-Deficient Effector Cells and Using the Combination of Hereditary T Lymphocytes: Analysis + Human CD4 Antigen-Specific Cytotoxicity Mediated by Essential Roles of Perforin in

YasukawaShirakata, Koji Sayama, Koji Hashimoto and Masaki Akihisa Mitsudome, Masafumi Zaitsu, Yasushi Ishida, YujiHasegawa, Taichi Azuma, Shinichi Hirose, Naohiro Suga, Fumio Yanai, Eiichi Ishii, Kensuke Kojima, Atsuhikohttp://www.jimmunol.org/content/170/4/2205J Immunol€2003; 170:2205-2213; ;Referenceshttp://www.jimmunol.org/content/170/4/2205.full#ref-list-1This article cites 48 articles, 28 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  T. Ley,et al.  Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.

[2]  S. Stevanović,et al.  Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1 , 2002, The Journal of Immunology.

[3]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[4]  K. Lucas,et al.  Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. , 2002, Blood.

[5]  A. Yoshimi,et al.  Epstein–Barr virus‐specific T‐cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation , 2002, British journal of haematology.

[6]  H. Takada,et al.  Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan , 2002, British journal of haematology.

[7]  A. Khanolkar,et al.  Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. , 2001, Virology.

[8]  L. Verdonck,et al.  Primary human keratinocytes as targets in predicting acute graft‐versus‐host disease following HLA‐identical bone marrow transplantation , 2000, British journal of haematology.

[9]  F. Rieux-Laucat,et al.  Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS) , 2000, Clinical and experimental immunology.

[10]  S. Fujita,et al.  Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.

[11]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[12]  J. Puck,et al.  Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. , 1999, Current opinion in pediatrics.

[13]  A. Hasegawa,et al.  Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells. , 1999, Journal of immunology.

[14]  A. Rothman,et al.  Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones , 1999, Journal of Virology.

[15]  K. Sayama,et al.  Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence , 1999, Journal of cellular physiology.

[16]  K. Okumura,et al.  Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. , 1999, Journal of immunology.

[17]  M. Colombo,et al.  Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. , 1998, Journal of immunology.

[18]  S. Mizutani,et al.  Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. , 1998, Medical and pediatric oncology.

[19]  S. Reed,et al.  Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. , 1998, Journal of immunology.

[20]  T. Miyawaki,et al.  Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. , 1998, International immunology.

[21]  V. Engelhard,et al.  Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. , 1997, Journal of immunology.

[22]  K. Tadokoro,et al.  Characterization of T-cell clones derived from peripheral blood lymphocytes of a patient with transfusion-associated graft-versus-host disease: Fas-mediated killing by CD4+ and CD8+ cytotoxic T-cell clones and tumor necrosis factor beta production by CD4+ T-cell clones. , 1997, Blood.

[23]  S. Yonehara,et al.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.

[24]  J. Falkenburg,et al.  Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. , 1995, Blood.

[25]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[26]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[27]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Siliciano,et al.  Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. , 1994, Journal of immunology.

[29]  K. Sayama,et al.  Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. , 1994, The Journal of investigative dermatology.

[30]  J. Tschopp,et al.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.

[31]  K. Okumura,et al.  Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. , 1994, Immunity.

[32]  P. Henkart.  Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. , 1994, Immunity.

[33]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[34]  S. Yonehara,et al.  Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Ju,et al.  Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[37]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[38]  P. Erb,et al.  Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. , 1994, Journal of immunology.

[39]  S. Fujita,et al.  Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones. , 1993, Blood.

[40]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[41]  T. Horiuchi,et al.  Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells. , 1991, Journal of immunology.

[42]  A. Öst,et al.  DIAGNOSTIC GUIDELINES FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS , 1991 .

[43]  K. Welsh,et al.  Interferon-gamma activates co-ordinate transcription of HLA-DR, DQ, and DP genes in cultured keratinocytes and requires de novo protein synthesis. , 1990, The Journal of investigative dermatology.

[44]  M. Yasukawa,et al.  Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. , 1988, Journal of immunology.

[45]  H. McFarland,et al.  Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. , 1984, Journal of immunology.

[46]  M. Yasukawa,et al.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. , 1984, Journal of immunology.

[47]  J. Strominger,et al.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Fujita,et al.  Expression of Perforin and Membrane-Bound Lymphotoxin ( Tumor Necrosis Factor-@ ) in Virus-Specific CD 4 + Human Cytotoxic Tce l l Clones , 2003 .

[49]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.

[50]  A. Ost,et al.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. , 1991, Seminars in oncology.